Red cell distribution width (RDW) is a laboratory measurement of variation in the volume of circulating red blood cells. It is commonly reported as part of a complete blood count and helps characterize anemia when interpreted alongside other blood-count measurements. A higher RDW indicates greater variation in cell size, a feature called anisocytosis. RDW is not a direct measurement of the physical width of individual cells and does not, by itself, identify a particular disease.
Measurement and reporting
Automated hematology analyzers measure or estimate the volumes of individual red blood cells and construct a cell-volume distribution. RDW summarizes the spread of that distribution. Laboratories commonly report one or both of two measures, RDW-CV and RDW-SD, which are not interchangeable.
RDW-CV
RDW-CV expresses the spread of red-cell volumes relative to the mean corpuscular volume (MCV):
Because MCV is the denominator, RDW-CV depends on both the absolute spread of cell volumes and their mean. Two samples with similar absolute volume variation may therefore have different RDW-CV values.
Many laboratories use adult reference intervals approximately within 11.5–14.5%, but the applicable interval depends on the analyzer, laboratory method, and reference population. The interval supplied with the laboratory report is the relevant basis for identifying a result as elevated.
RDW-SD
RDW-SD is generally reported in femtoliters, the same volume unit used for MCV. Despite its name, on commonly used analyzers it is measured as the width of the red-cell volume histogram at 20% of the histogram’s peak height, rather than as the mathematical standard deviation of all measured volumes.
Unlike RDW-CV, this measurement is not divided by MCV. Its interpretation nevertheless depends on the analyzer’s measurement method and the shape of the cell-volume distribution.
Biological basis
Circulating red blood cells are not all identical in volume. Their size reflects their production in the bone marrow, maturation, and subsequent changes during circulation. RDW rises when the circulating population becomes more heterogeneous.
Several processes can produce this pattern:
- Nutrient deficiency: Iron, vitamin B12, or folate deficiency can alter red-cell production and increase size variation.
- Increased red-cell turnover: After blood loss or during hemolysis, increased release of immature red cells, called reticulocytes, can broaden the volume distribution because these cells are generally larger than mature red cells.
- Mixed cell populations: A blood transfusion may introduce cells whose volumes differ from those already circulating.
- Changing red-cell production: During recovery from a deficiency, newly produced cells may differ in size from older cells that remain in circulation.
RDW therefore reflects the composition of the circulating red-cell population, not a single underlying mechanism.
Role in evaluating anemia
RDW is most useful in combination with hemoglobin concentration, MCV, the red-cell count, and other findings. Common patterns include:
| Blood-count pattern | Possible interpretation |
|---|---|
| Low MCV with elevated RDW | Often occurs in [[iron-deficiency-anemia |
| Low MCV with relatively normal RDW | May occur in [[thalassemia |
| High MCV with elevated RDW | May occur with vitamin B12 or folate deficiency and other causes of abnormal red-cell production |
| Normal MCV with elevated RDW | May reflect early deficiency or a mixture of small and large cells whose average volume falls within the reference interval |
These patterns overlap and are not diagnostic rules. A normal RDW does not exclude iron deficiency, and an elevated RDW does not exclude thalassemia.
An important limitation of MCV is that it is an average: a mixture of small and large cells can produce a normal mean. RDW may reveal the underlying heterogeneity, although inspection of the analyzer histogram or a blood smear can provide information that a single numerical index cannot. In a differential diagnosis, RDW is interpreted with clinical history and, where relevant, iron studies, vitamin measurements, and reticulocyte counts.
Associations beyond anemia
Studies have examined RDW as a biomarker associated with outcomes in conditions including heart failure, sepsis, and chronic kidney disease. Elevated RDW has been associated with worse outcomes in numerous observational patient populations.
These associations are nonspecific. RDW can reflect several overlapping influences, including nutritional deficiency, altered red-cell turnover, inflammation, and coexisting illness. An association with an outcome does not establish that RDW causes that outcome or that changing RDW independently improves it. Its usefulness for prognosis depends on the disease setting and the other information available.
Limitations and analytical influences
RDW does not measure red-cell number, hemoglobin content, or oxygen-carrying capacity. A person can have elevated RDW without anemia, or anemia with a normal RDW. A low RDW generally indicates a relatively uniform cell population and has limited diagnostic significance on its own.
Results can also be influenced by sample storage, temperature, red-cell swelling, cell clumping, and analyzer-specific processing. Markedly abnormal cell populations may complicate the calculation or interpretation of the histogram. Recent transfusion and changes in red-cell production can make results difficult to compare over time.
Differences in methods and reference intervals limit direct comparison between laboratories. RDW-CV percentages and RDW-SD values in femtoliters describe related but distinct features and cannot be substituted for one another.